The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Patrick Deval L since year 2005.
The trader's CIK number is 1053466.
At the time of this reporting, Patrick Deval L is the Director of Global Blood Therapeutics, Inc. .
(stock ticker symbol GBT).
See this page for all insider trading activities at Global Blood Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-07-06||GBT||Global Blood Therapeutics, Inc.||Sale||42,379||43.40||1,839,290|
|2018-07-06||GBT||Global Blood Therapeutics, Inc.||Option Ex||42,379||17.96||761,253|
|2017-07-25||GBT||Global Blood Therapeutics, Inc.||Sale||27,053||29.69||803,203|
|2017-07-25||GBT||Global Blood Therapeutics, Inc.||Option Ex||27,053||11.12||300,964|
|2015-08-17||GBT||Global Blood Therapeutics, Inc.||Buy||2,500||20.00||50,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patrick Deval L (Director of Global Blood Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.